Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
RIDA®GENE Flu & SARS-CoV-2
Intended use:For in vitro diagnostic use. The RIDA®GENE Flu & SARS-CoV-2 test, performed on the LightCycler® 480II real-time PCR instrument, is a multiplex real-time RT-PCR for the direct [...]
RIDA®GENE SARS-CoV-2
Intended use:For in vitro diagnostic use. The RIDA®GENE SARS-CoV-2 test, which will be performed on the Roche LightCycler® 480II, is a multiplex real-time RT-PCR for the direct qualitative [...]
Quality controls for SARS-CoV-2 rapid tests and RT-PCR
We complement our control reagent portfolio with new controls including SARS-CoV2 positive and negative controls, as well as all-encompassing validation and verification kits for respiratory and [...]
Coronavirus
All RIDA®GENE SARS CoV-2 tests detect the new variant Omicron (B1.1.529) with the usual sensitivity and reliability
The Omicron variant does not show any mutations in the areas detected by our assays and is therefore positively detected by RIDA®GENE SARS-CoV-2 (Art. No. PG6815/ PG6820) and RIDA®GENE Flu & [...]
Back to school in the time of the coronavirus – what can we expect?
The COVID-19 infection figures continue to rise and with them the fear: How long can regular school operations be maintained? Experts warn of renewed school closings and recommend specific measures.
Coronavirus test kit receives CE label
In February 2020, R-Biopharm was one of the first diagnostics companies worldwide to launch a test kit for the novel coronavirus SARS-CoV-2. Now, the test has received the CE label and is thus [...]
Respiratory infections
Mpox (Monkeypox)
The WHO recommends expanding testing for Mpox (Monkeypox) The newly circulating virus variant Mpox clade Ib is much more contagious and can cause more severe courses of disease than the variant [...]